Merz Therapeutics Gmbh
Clinical trials sponsored by Merz Therapeutics Gmbh, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a Botox-Like shot stop migraines before they start? Results expected Mar 2027 (estimated)
- Can an inhaled levodopa ease Parkinson's OFF episodes? a study asks patients. Results expected Aug 2027 (estimated)
-
Can a Botox-Like shot stop chronic migraines? big trial underway
Disease control Recruiting nowThis phase 3 trial tests whether Xeomin (a botulinum toxin type A injection) can reduce the number of migraine days in people with chronic migraine. About 780 participants will receive either Xeomin or a placebo injected into head and neck muscles every 12 weeks for up to 55 week…
Phase 3 • Sponsor: Merz Therapeutics GmbH • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a Botox-Like shot stop migraines before they start?
Prevention Recruiting nowThis phase 3 trial tests whether injections of Xeomin (a botulinum toxin type A) into head and neck muscles can prevent episodic migraines. About 990 adults with episodic migraine will receive either Xeomin or a placebo every 12 weeks for up to 55 weeks. The main goal is to see i…
Phase 3 • Sponsor: Merz Therapeutics GmbH • Aim: Prevention
Last updated Sep 04, 2026 00:00 UTC